10x Genomics, Inc. — Director's Dealing 2021

Apr 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-04-06

Reporting Person: Saxonov Serge (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-06	Class A Common Stock	M	5208	$5.04	Acquired	885676	Direct
2021-04-06	Class A Common Stock	M	9792	$11.48	Acquired	895468	Direct
2021-04-06	Class A Common Stock	S	800	$190.5813	Disposed	894668	Direct
2021-04-06	Class A Common Stock	S	200	$192.465	Disposed	894468	Direct
2021-04-06	Class A Common Stock	S	1900	$193.4758	Disposed	892568	Direct
2021-04-06	Class A Common Stock	S	1826	$194.4425	Disposed	890742	Direct
2021-04-06	Class A Common Stock	S	1097	$195.8131	Disposed	889645	Direct
2021-04-06	Class A Common Stock	S	5428	$196.6143	Disposed	884217	Direct
2021-04-06	Class A Common Stock	S	2849	$197.4746	Disposed	881368	Direct
2021-04-06	Class A Common Stock	S	800	$198.6913	Disposed	880568	Direct
2021-04-06	Class A Common Stock	S	100	$199.41	Disposed	880468	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-06	Stock Option (right to buy)	$5.04	M	5208	Disposed	2028-11-02	Class A Common Stock (5208)	Direct
2021-04-06	Stock Option (right to buy)	$11.48	M	9792	Disposed	2029-05-10	Class A Common Stock (9792)	Direct

Footnotes

F1: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $189.99 to $190.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3: This transaction was executed in multiple trades at prices ranging from $191.99 to $192.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F4: This transaction was executed in multiple trades at prices ranging from $193.00 to $193.97. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F5: This transaction was executed in multiple trades at prices ranging from $194.00 to $194.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F6: This transaction was executed in multiple trades at prices ranging from $195.08 to $196.04. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F7: This transaction was executed in multiple trades at prices ranging from $196.09 to $197.08. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F8: This transaction was executed in multiple trades at prices ranging from $197.10 to $198.04. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F9: This transaction was executed in multiple trades at prices ranging from $198.36 to $199.10. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F10: This option, originally for 250,000 shares, of which 155,010 have been exercised, vested as to one forty-eighth of the shares on October 1, 2018, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

F11: This option, originally for 145,786 shares, of which 38,698 have been exercised, vested as to one forty-eighth of the shares on May 1, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.